BCAL Diagnostics LimitedASX: BDX

AGM 2026 Presentation

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX · · 19 pages · English

Release

FY26 Annual General MeetingChief Executive Officer: Anne-Louise Arnett19 October 2026Chair: Jayne ShawCEO’s AddressAn Australian health care company pioneering diagnostics for earlier cancer detectionClose the gaps in early cancer detection.Our PurposeExpand early diagnostic access by creating...

BCAL Diagnostics Limited on 6ix

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases